Literature DB >> 9596749

Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears.

X D Qu1, R I Lehrer.   

Abstract

We examined human tears for molecules that killed gram-positive bacteria. The principal mediator of bactericidal activity against staphylococci proved to be a calcium-dependent enzyme, secretory phospholipase A2. Whereas the concentration of secretory phospholipase A2 in the normal tear film exceeded 30 microg/ml, only 1.1 ng (<0.1 nM) of the enzyme per ml sufficed to kill Listeria monocytogenes and 15 to 80 ng/ml killed Staphylococcus aureus. Despite its efficacy against gram-positive bacteria, secretory phospholipase A2 lacked bactericidal activity against gram-negative organisms (Escherichia coli, Salmonella typhimurium, and Pseudomonas aeruginosa) when tested in the ionic environment of tears. Given the presence of secretory phospholipase A2 in tears, intestinal secretions, and leukocytes, this enzyme may play a substantial role in innate mucosal and systemic bactericidal defenses against gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9596749      PMCID: PMC108271          DOI: 10.1128/IAI.66.6.2791-2797.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Regulation of phospholipase A2 enzymes: selective inhibitors and their pharmacological potential.

Authors:  K B Glaser
Journal:  Adv Pharmacol       Date:  1995

2.  Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

Authors:  B Guidet; O Piot; J Masliah; V Barakett; E Maury; G Bereziat; G Offenstadt
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Plasma levels of type II phospholipase A2 and cytokines in patients with sepsis.

Authors:  S Endo; K Inada; H Nakae; T Takakuwa; Y Yamada; T Suzuki; S Taniguchi; M Yoshida; M Ogawa; H Teraoka
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1995-12

4.  The two distinct phospholipases C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell-to-cell spread.

Authors:  G A Smith; H Marquis; S Jones; N C Johnston; D A Portnoy; H Goldfine
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 5.  Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.

Authors:  K Tanaka; H Arita
Journal:  Agents Actions Suppl       Date:  1995

6.  Expression of group II phospholipase A2 in the human gastrointestinal tract.

Authors:  T J Nevalainen; J M Grönroos; M Kallajoki
Journal:  Lab Invest       Date:  1995-02       Impact factor: 5.662

7.  The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Authors:  Y Weinrauch; P Elsbach; L M Madsen; A Foreman; J Weiss
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

8.  A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains.

Authors:  B P Kennedy; P Payette; J Mudgett; P Vadas; W Pruzanski; M Kwan; C Tang; D E Rancourt; W A Cromlish
Journal:  J Biol Chem       Date:  1995-09-22       Impact factor: 5.157

9.  Bactericidal properties of murine intestinal phospholipase A2.

Authors:  S S Harwig; L Tan; X D Qu; Y Cho; P B Eisenhauer; R I Lehrer
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more
  65 in total

1.  Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus.

Authors:  M E Dominiecki; J Weiss
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

Authors:  Yi Wei; Seth P Epstein; Shima Fukuoka; Neil P Birmingham; Xiu-Min Li; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

Review 3.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 4.  Epithelial antimicrobial defence of the skin and intestine.

Authors:  Richard L Gallo; Lora V Hooper
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

Review 5.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

Review 6.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 7.  Dry eye disease and microbial keratitis: is there a connection?

Authors:  Srihari Narayanan; Rachel L Redfern; William L Miller; Kelly K Nichols; Alison M McDermott
Journal:  Ocul Surf       Date:  2013-01-29       Impact factor: 5.033

Review 8.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

9.  Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores.

Authors:  Maria Fluckinger; Hubertus Haas; Petra Merschak; Ben J Glasgow; Bernhard Redl
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

10.  Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3.

Authors:  Tomaz Koprivnjak; Christopher Weidenmaier; Andreas Peschel; Jerrold P Weiss
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.